PubMed:8506326
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 250-260 | gene:3558 | denotes | lymphokine |
| T1 | 171-203 | disease:C0085110 | denotes | severe combined immunodeficiency |
| R1 | T0 | T1 | associated_with | lymphokine,severe combined immunodeficiency |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-40 | protein | denotes | lymphokine |
| T2 | 141-154 | cell_type | denotes | T lymphocytes |
| T3 | 250-266 | DNA | denotes | lymphokine genes |
| T4 | 280-283 | DNA | denotes | IL2 |
| T5 | 285-288 | DNA | denotes | IL3 |
| T6 | 290-293 | DNA | denotes | IL4 |
| T7 | 299-302 | DNA | denotes | IL5 |
| T8 | 317-329 | protein | denotes | interleukins |
| T9 | 346-350 | protein | denotes | IL-2 |
| T10 | 352-354 | protein | denotes | -3 |
| T11 | 356-358 | protein | denotes | -4 |
| T12 | 364-366 | protein | denotes | -5 |
| T13 | 418-431 | cell_type | denotes | T lymphocytes |
| T14 | 443-462 | protein | denotes | trans-acting factor |
| T15 | 486-502 | DNA | denotes | lymphokine genes |
| T16 | 531-546 | protein | denotes | nuclear factors |
| T17 | 566-579 | cell_type | denotes | T lymphocytes |
| T18 | 621-638 | DNA | denotes | regulatory region |
| T19 | 642-645 | DNA | denotes | IL2 |
| T20 | 647-667 | protein | denotes | Nuclear factor NF-kB |
| T21 | 669-689 | protein | denotes | activation protein 1 |
| T22 | 691-695 | protein | denotes | AP-1 |
| T23 | 698-703 | protein | denotes | OCT-1 |
| T24 | 709-717 | protein | denotes | NF-IL-2B |
| T25 | 780-815 | protein | denotes | nuclear factor of activated T cells |
| T26 | 817-822 | protein | denotes | NF-AT |
| T27 | 855-867 | DNA | denotes | IL2 enhancer |
| T28 | 878-905 | DNA | denotes | NF-AT-like response element |
| T29 | 921-933 | DNA | denotes | IL4 enhancer |
| T30 | 982-987 | protein | denotes | NF-AT |
| T31 | 1077-1090 | cell_type | denotes | T lymphocytes |
| T32 | 1145-1179 | protein | denotes | chloramphenicol acetyl transferase |
| T33 | 1181-1184 | protein | denotes | CAT |
| T34 | 1218-1239 | DNA | denotes | IL2 regulatory region |
| T35 | 1270-1288 | DNA | denotes | enhancer sequences |
| T36 | 1321-1342 | DNA | denotes | IL2 regulatory region |
| T37 | 1367-1385 | DNA | denotes | NF-AT-binding site |
| T38 | 1455-1463 | DNA | denotes | CAT gene |
| T39 | 1505-1541 | DNA | denotes | OCT-1 proximal (OCT-1p)-binding site |
| T40 | 1643-1648 | protein | denotes | NF-AT |
| T41 | 1675-1685 | protein | denotes | lymphokine |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 8506326-1#146#156#gene3558 | 250-260 | gene3558 | denotes | lymphokine |
| 8506326-1#195#198#gene3567 | 299-302 | gene3567 | denotes | IL5 |
| 8506326-1#67#99#diseaseC0085110 | 171-203 | diseaseC0085110 | denotes | severe combined immunodeficiency |
| 146#156#gene355867#99#diseaseC0085110 | 8506326-1#146#156#gene3558 | 8506326-1#67#99#diseaseC0085110 | associated_with | lymphokine,severe combined immunodeficiency |
| 195#198#gene356767#99#diseaseC0085110 | 8506326-1#195#198#gene3567 | 8506326-1#67#99#diseaseC0085110 | associated_with | IL5,severe combined immunodeficiency |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-103 | Sentence | denotes | Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency. |
| S2 | 104-368 | Sentence | denotes | We have previously reported that the T lymphocytes of a child with severe combined immunodeficiency are defective in the transcription of several lymphokine genes that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5). |
| S3 | 369-646 | Sentence | denotes | To determine whether the defect in the patient's T lymphocytes involved a trans-acting factor common to the affected lymphokine genes, we examined the ability of nuclear factors from the patient's T lymphocytes to bind response elements present in the regulatory region of IL2. |
| S4 | 647-747 | Sentence | denotes | Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal. |
| S5 | 748-947 | Sentence | denotes | In contrast, the binding of the nuclear factor of activated T cells (NF-AT) to its response element in the IL2 enhancer and to an NF-AT-like response element present in the IL4 enhancer was abnormal. |
| S6 | 948-1289 | Sentence | denotes | To ascertain whether the abnormal NF-AT binding activity was related to an impaired function, we transfected patient and control T lymphocytes with constructs containing the reporter gene encoding chloramphenicol acetyl transferase (CAT) under the control of the entire IL2 regulatory region or of multimers of individual enhancer sequences. |
| S7 | 1290-1441 | Sentence | denotes | CAT expression directed by the IL2 regulatory region or by a multimer of the NF-AT-binding site was markedly lower in the patient relative to controls. |
| S8 | 1442-1581 | Sentence | denotes | In contrast, CAT gene expression directed by a multimer of the OCT-1 proximal (OCT-1p)-binding site was equivalent in patient and controls. |
| S9 | 1582-1713 | Sentence | denotes | These results indicate that an abnormality of/or influencing NF-AT may underlie the multiple lymphokine deficiency in this patient. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 55-102 | NP | denotes | a patient with severe combined immunodeficiency |
| C1 | 19-102 | NP | denotes | a multiple lymphokine deficiency in a patient with severe combined immunodeficiency |
| C4 | 158-203 | NP | denotes | a child with severe combined immunodeficiency |
| C3 | 137-203 | NP | denotes | the T lymphocytes of a child with severe combined immunodeficiency |
| C6 | 242-266 | NP | denotes | several lymphokine genes |
| C7 | 267-271 | NP | denotes | that |
| C9 | 280-283 | NP | denotes | IL2 |
| C8 | 280-302 | NP | denotes | IL2, IL3, IL4, and IL5 |
| C5 | 221-302 | NP | denotes | the transcription of several lymphokine genes that include IL2, IL3, IL4, and IL5 |
| C10 | 304-309 | NP | denotes | which |
| C12 | 317-331 | NP | denotes | interleukins 2 |
| C11 | 317-367 | NP | denotes | interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5) |
| C14 | 404-417 | NP | denotes | the patient's |
| C13 | 404-431 | NP | denotes | the patient's T lymphocytes |
| C15 | 473-502 | NP | denotes | the affected lymphokine genes |
| C17 | 552-565 | NP | denotes | the patient's |
| C16 | 552-579 | NP | denotes | the patient's T lymphocytes |
| C18 | 642-645 | NP | denotes | IL2 |
| C19 | 776-823 | NP | denotes | the nuclear factor of activated T cells (NF-AT) |
| C20 | 827-830 | NP | denotes | its |
| C21 | 1057-1064 | NP | denotes | patient |
| C22 | 1207-1239 | NP | denotes | the entire IL2 regulatory region |
| C23 | 1317-1342 | NP | denotes | the IL2 regulatory region |
| C24 | 1408-1419 | NP | denotes | the patient |
| C25 | 1560-1567 | NP | denotes | patient |
| C27 | 1700-1712 | NP | denotes | this patient |
| C26 | 1662-1712 | NP | denotes | the multiple lymphokine deficiency in this patient |
| R1 | C4 | C2 | coref-ident | a child with severe combined immunodeficiency,a patient with severe combined immunodeficiency |
| R2 | C7 | C6 | coref-relat | that,several lymphokine genes |
| R3 | C10 | C5 | coref-relat | which,"the transcription of several lymphokine genes that include IL2, IL3, IL4, and IL5" |
| R4 | C12 | C9 | coref-ident | interleukins 2,IL2 |
| R5 | C11 | C8 | coref-ident | "interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5)","IL2, IL3, IL4, and IL5" |
| R6 | C14 | C3 | coref-ident | the patient's,the T lymphocytes of a child with severe combined immunodeficiency |
| R7 | C13 | C4 | coref-ident | the patient's T lymphocytes,a child with severe combined immunodeficiency |
| R8 | C15 | C6 | coref-ident | the affected lymphokine genes,several lymphokine genes |
| R9 | C17 | C13 | coref-ident | the patient's,the patient's T lymphocytes |
| R10 | C16 | C14 | coref-ident | the patient's T lymphocytes,the patient's |
| R11 | C18 | C11 | coref-ident | IL2,"interleukins 2, 3, 4, and 5 (IL-2, -3, -4, and -5)" |
| R12 | C20 | C19 | coref-pron | its,the nuclear factor of activated T cells (NF-AT) |
| R13 | C21 | C17 | coref-ident | patient,the patient's |
| R14 | C23 | C22 | coref-ident | the IL2 regulatory region,the entire IL2 regulatory region |
| R15 | C24 | C17 | coref-ident | the patient,the patient's |
| R16 | C25 | C24 | coref-ident | patient,the patient |
| R17 | C27 | C25 | coref-ident | this patient,patient |
| R18 | C26 | C1 | coref-ident | the multiple lymphokine deficiency in this patient,a multiple lymphokine deficiency in a patient with severe combined immunodeficiency |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-40 | protein_family_or_group | denotes | lymphokine |
| T2 | 70-102 | other_name | denotes | severe combined immunodeficiency |
| T3 | 141-154 | cell_type | denotes | T lymphocytes |
| T4 | 171-203 | other_name | denotes | severe combined immunodeficiency |
| T5 | 250-260 | protein_family_or_group | denotes | lymphokine |
| T6 | 261-266 | DNA_family_or_group | denotes | genes |
| T7 | 280-283 | DNA_domain_or_region | denotes | IL2 |
| T8 | 285-288 | DNA_domain_or_region | denotes | IL3 |
| T9 | 290-293 | DNA_domain_or_region | denotes | IL4 |
| T10 | 299-302 | DNA_domain_or_region | denotes | IL5 |
| T11 | 317-329 | protein_family_or_group | denotes | interleukins |
| T12 | 346-350 | protein_molecule | denotes | IL-2 |
| T13 | 352-354 | protein_molecule | denotes | -3 |
| T14 | 356-358 | protein_molecule | denotes | -4 |
| T15 | 364-366 | protein_molecule | denotes | -5 |
| T16 | 418-431 | cell_type | denotes | T lymphocytes |
| T17 | 443-462 | protein_family_or_group | denotes | trans-acting factor |
| T18 | 486-496 | protein_family_or_group | denotes | lymphokine |
| T19 | 497-502 | DNA_family_or_group | denotes | genes |
| T20 | 531-546 | protein_family_or_group | denotes | nuclear factors |
| T21 | 566-579 | cell_type | denotes | T lymphocytes |
| T22 | 621-638 | DNA_domain_or_region | denotes | regulatory region |
| T23 | 642-645 | DNA_domain_or_region | denotes | IL2 |
| T24 | 647-667 | protein_molecule | denotes | Nuclear factor NF-kB |
| T25 | 669-689 | protein_molecule | denotes | activation protein 1 |
| T26 | 691-695 | protein_molecule | denotes | AP-1 |
| T27 | 698-703 | protein_molecule | denotes | OCT-1 |
| T28 | 709-717 | protein_molecule | denotes | NF-IL-2B |
| T29 | 718-734 | other_name | denotes | binding activity |
| T30 | 780-797 | protein_molecule | denotes | nuclear factor of |
| T31 | 798-807 | cell_type | denotes | activated |
| T32 | 808-815 | cell_type | denotes | T cells |
| T33 | 817-822 | protein_molecule | denotes | NF-AT |
| T34 | 855-858 | DNA_domain_or_region | denotes | IL2 |
| T35 | 878-883 | protein_molecule | denotes | NF-AT |
| T36 | 921-933 | DNA_domain_or_region | denotes | IL4 enhancer |
| T37 | 973-981 | other_name | denotes | abnormal |
| T38 | 982-987 | protein_molecule | denotes | NF-AT |
| T39 | 1077-1090 | cell_type | denotes | T lymphocytes |
| T40 | 1145-1179 | protein_molecule | denotes | chloramphenicol acetyl transferase |
| T41 | 1181-1184 | protein_molecule | denotes | CAT |
| T42 | 1218-1221 | DNA_domain_or_region | denotes | IL2 |
| T43 | 1270-1288 | DNA_domain_or_region | denotes | enhancer sequences |
| T44 | 1321-1324 | DNA_domain_or_region | denotes | IL2 |
| T45 | 1367-1372 | protein_molecule | denotes | NF-AT |
| T46 | 1412-1419 | multi_cell | denotes | patient |
| T47 | 1455-1463 | DNA_family_or_group | denotes | CAT gene |
| T48 | 1505-1541 | DNA_domain_or_region | denotes | OCT-1 proximal (OCT-1p)-binding site |
| T49 | 1643-1648 | protein_molecule | denotes | NF-AT |
| T50 | 1675-1685 | protein_family_or_group | denotes | lymphokine |
| T51 | 1705-1712 | multi_cell | denotes | patient |